These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6138728)

  • 1. Electrophysiological studies on EMD 23 448, an indolyl-3-butylamine, in the rat: a putative selective dopamine autoreceptor agonist.
    Chiodo LA; Bunney BS
    Neuropharmacology; 1983 Sep; 22(9):1087-93. PubMed ID: 6138728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The characterization of the dopaminergic profile of EMD 23,448, and indolyl-3-butylamine: selective actions on presynaptic and supersensitive postsynaptic DA receptor populations.
    Goldstein M; Fuxe K; Meller E; Seyfried CA; Agnati L; Mascagni FM
    J Neural Transm; 1987; 70(3-4):193-215. PubMed ID: 2890706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M; White FJ
    Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonist activity of EMD 23,448.
    Martin GE; Pettibone DJ
    J Neural Transm; 1985; 61(1-2):115-23. PubMed ID: 4038993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The putative dopamine autoreceptor agonist B-HT 920 decreases nigral dopamine cell firing rate and prolactin release in rat.
    Eriksson E; Svensson K; Clark D
    Life Sci; 1985 May; 36(19):1819-27. PubMed ID: 3990512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons.
    Chiodo LA; Bannon MJ; Grace AA; Roth RH; Bunney BS
    Neuroscience; 1984 May; 12(1):1-16. PubMed ID: 6462443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine autoreceptor mediation of the effects of apomorphine on serotonin neurons.
    Lee EH; Geyer MA
    Pharmacol Biochem Behav; 1984 Aug; 21(2):301-11. PubMed ID: 6207549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine"autoreceptors": pharmacological characterization by microiontophoretic single cell recording studies.
    Aghajanian GK; Bunney BS
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):1-7. PubMed ID: 193046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist and antagonist actions of lisuride on dopamine neurons: electrophysiological evidence.
    Gessa GL
    J Neural Transm Suppl; 1988; 27():201-10. PubMed ID: 3165435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system.
    Clark D; Engberg G; Pileblad E; Svensson TH; Carlsson A; Freeman AS; Bunney BS
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):344-54. PubMed ID: 4033804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol.
    Xu D; Karain B; Brantley E; Shi WX
    J Pharmacol Exp Ther; 2011 May; 337(2):533-9. PubMed ID: 21330359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantia nigra dopamine neurons: alterations in basal discharge rates and autoreceptor sensitivity induced by estrogen.
    Chiodo LA; Caggiula AR
    Neuropharmacology; 1983 May; 22(5):593-9. PubMed ID: 6877536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness to 'autoreceptor' doses of apomorphine inversely correlated with the firing rate of dopaminergic A9 neurons: action of baclofen.
    Mereu G; Muntoni F; Calabresi P; Romani F; Boi V; Gessa GL
    Neurosci Lett; 1986 Apr; 65(2):161-6. PubMed ID: 3714103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential electrophysiological effects of 3-PPP and its enantiomers on dopamine autoreceptors and postsynaptic receptors.
    Bergstrom DA; Carlson JH; Bromley SD; Jackson DM; Walters JR
    Eur J Pharmacol; 1986 May; 124(1-2):75-84. PubMed ID: 3720847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology.
    Grace AA; Bunney BS
    Brain Res; 1985 May; 333(2):285-98. PubMed ID: 3995296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptor-mediated inhibition of dopaminergic excitatory input to caudate neurons from the substantia nigra.
    Nabatame H; Sasa M; Takaori S; Kameyama M
    Jpn J Pharmacol; 1988 Apr; 46(4):387-95. PubMed ID: 3404769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.